<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The objective of the study was to investigate the role of endothelin-1 in the pathogenesis of <z:hpo ids='HP_0100324'>scleroderma</z:hpo> renal crisis in patients with systemic <z:mp ids='MP_0000612'>sclerosis</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>We used immunohistochemical analysis with anti-endothelin-1 and anti-<z:e sem="disease" ids="C0042974" disease_type="Disease or Syndrome" abbrv="">von Willebrand</z:e> factor antibodies in comparing kidney biopsies from patients with systemic <z:mp ids='MP_0000612'>sclerosis</z:mp> and <z:hpo ids='HP_0100324'>scleroderma</z:hpo> renal crisis (n = 14); from <z:mpath ids='MPATH_458'>normal</z:mpath> kidneys (n = 5); and from patients with typical <z:hpo ids='HP_0005575'>hemolytic uremic syndrome</z:hpo> and <z:e sem="disease" ids="C0034155" disease_type="Disease or Syndrome" abbrv="">thrombotic microangiopathy</z:e> (n = 5), <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (n = 6), diabetic <z:hpo ids='HP_0000112'>nephropathy</z:hpo> (n = 5), <z:e sem="disease" ids="C0027721" disease_type="Disease or Syndrome" abbrv="">minimal change disease</z:e> with <z:chebi fb="0" ids="4031">cyclosporine</z:chebi> toxicity (n = 5), or <z:e sem="disease" ids="C0948347" disease_type="Disease or Syndrome" abbrv="">nephroangiosclerosis</z:e> (n = 5) </plain></SENT>
<SENT sid="2" pm="."><plain>Kidney biopsies from <z:hpo ids='HP_0000001'>all</z:hpo> systemic <z:mp ids='MP_0000612'>sclerosis</z:mp> patients presented specific lesions: glomerular lesions with thickened capillary walls (n = 6, 42.8%), <z:mp ids='MP_0011430'>mesangiolysis</z:mp> (n = 3, 21.4%), fibrin <z:e sem="disease" ids="C0087086" disease_type="Disease or Syndrome" abbrv="">thrombi</z:e> (n = 3, 21.4%), <z:mpath ids='MPATH_159'>hypertrophy</z:mpath> of juxtaglomerular apparatus (n = 5, 35.7%), arteriolar lesions showing mucinous intimal thickening and lumen mucoid occlusions (n = 13, 92.8%), proliferation of intimal cells (ie, "onion-skin" lesions; n = 13, 92.8%), fibrinoid <z:mp ids='MP_0001651'>necrosis</z:mp> (n = 3, 21.4%), and fibrin <z:mp ids='MP_0005048'>thrombosis</z:mp> (n = 4, 28.6%) </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0011010'>Chronic</z:hpo> lesions in large arteries showed modifications such as fibrous intimal thickening (n = 13, 92.8%) </plain></SENT>
<SENT sid="4" pm="."><plain>The pattern of endothelial staining for endothelin-1 in both glomeruli and arteriolar lesions appears to be specific for <z:hpo ids='HP_0100324'>scleroderma</z:hpo> renal crisis </plain></SENT>
<SENT sid="5" pm="."><plain>Glomerular endothelin-1 staining without arteriolar staining was seen in <z:hpo ids='HP_0005575'>hemolytic uremic syndrome</z:hpo>; and isolated arteriolar staining (without glomerular staining) was seen in a number of conditions including antiphospholipid <z:hpo ids='HP_0000112'>nephropathy</z:hpo>, <z:chebi fb="0" ids="4031">cyclosporine</z:chebi> toxicity, and diabetic <z:hpo ids='HP_0000112'>nephropathy</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>Endothelin-1 is overexpressed in glomeruli and arterioles of patients with <z:hpo ids='HP_0100324'>scleroderma</z:hpo> renal crisis, which suggests that endothelin-1 might be a therapeutic target in this condition </plain></SENT>
</text></document>